2000 (13 POSTS)
Mcnamara JF, Lombardo H, Pillai SK, Jensen I , Albericio F, Kates SK. 2000. An efficient solid-phase strategy for the construction of chemokines. J Pept Sci 6(10):512–518; doi: 10.1002/1099-1387(200010)6:10<512::AID-PSC269>3.0.CO;2-A .
View Abstract
Topics: chemokines , solid phase synthesis
Andersen ME, Sarangapani R, Gentry PR, Clewell HJ, Covington TR , Frederick CB. 2000. Application of a hybrid CFD-PBPK nasal dosimetry model in an inhalation risk assessment: An example with acrylic acid. Toxicol Sci 57:312–325.
View Abstract
Topics: Toxicology
Thompson CM , Capdevila JH, Strobel HW. 2000. Recombinant P450 2D18 metabolism of dopamine and arachidonic acid. J Pharmacol Exper Ther 294(3):1120–1130.
View Abstract
Topics: pharmacokinetics , Toxicology
Kelsh MA , Kheifets LI, Smith RW. 2000. The impact of work environment, utility and sampling design on occupational exposure summaries. AIHA J 61(2):174–182; doi: 10.1080/15298660008984526 .
View Abstract
Topics: Electric and Magnetic Fields (EMF) , Occupational
Jankowski-Hennig MA, Clegg MS, Daston GP, Rogers JM , Keen CL. 2000. Zinc-deficient rat embryos have increased caspase 3-like activity and apoptosis. Biochem Biophys Res Commun 271(1):250–256; doi: 10.1006/bbrc.2000.2608 .
View Abstract
Topics: Toxicology , Zinc
Lau C, Anderson ME, Crawford-Brown DJ, Kavlock RJ, Kimmel CA, Knudsen TB, Muneoka K, Rogers JM , Setzer RW, Smith G, Tyl R. 2000. Evaluation of biologically based dose-response modeling for developmental toxicity: A workshop report. Regul Toxicol Pharmacol 31(2):190–199; 10.1006/rtph.1999.1360 .
View Abstract
Topics: modeling , risk assessment , Toxicology
Clewell HJ III, Gentry PR, Allen BC, Covington TR , Gearhart JM. 2000. Development of a physiologically-based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Environ Health Perspect 108(Suppl 2):283–305.
View Abstract
Topics: Toxicology
Morgan RW, Kelsh MA , Zhao K, Exuzides KA, Heringer S, Negrete W. 2000. Radiofrequency exposure and mortality from cancers of the brain and lymphatic/hematopoietic system. Epidemiol 11:118–127.
View Abstract
Topics: Electric and Magnetic Fields (EMF)
Greenland S, Sheppard AR, Kaune WT, Poole C, Kelsh MA . 2000. A pooled analysis of magnetic fields, wire codes and childhood leukemia. Epidemiol 227(2):294–306.
View Abstract
Topics: Cancer , Electric and Magnetic Fields (EMF)
Choksi NY , Nix WB, Wyrick SD, Booth RG. 2000. A novel phenylaminotetralin (PAT) recognizes histamine H1 receptors and stimulates dopamine synthesis in vivo in rat brain. Brain Research 852(1):151–160; doi: 10.1016/s0006-8993(99)02228-3 .
View Abstract
Topics: Epidemiology , Toxicology
1999 (3 POSTS)
Clewell HJ, Gearhart JM, Gentry PR, Covington TR , Van Landingham CB, Crump KS, and Shipp AM. 1999. Evaluation of the uncertainty in an oral reference dose for methylmercury due to interindividual variability in pharmacokinetics. Risk Anal 19:541–552.
View Abstract
Topics: Toxicology
Trippodo NC, Fox M, Monticello TM , Panchal BC, Asaad MM. 1999. Vasopeptidase inhibition with omapatrilat improves cardiac geometry and survival in cardiomyopathic hamsters more than does ACE inhibition with captopril. J Cardiovasc Pharmacol 34(6):782-790; doi: 10.1097/00005344-199912000-00003 .
View Abstract
Topics: vasopeptidase inhibitors
Zucker RM, Hunter ES III, Rogers JM . 1999. Apoptosis and morphology in mouse embryos by confocal laser scanning microscopy. Methods 18(4):473–480; doi: 10.1006/meth.1999.0815 .
View Abstract
Topics: microscopy , Toxicology
1998 (8 POSTS)
Kodavanti PR, Derr-Yellin EC, Mundy WR, Shafer TJ, Herr DW Barone S, Choksi, NY , MacPhail RC, Tilson HA. 1998. Repeated exposure of Aroclor 1254 causes brain region-specific changes in intracellular Ca2+ buffering and protein kinase C activity in the absence of changes in tyrosine hydroxylase. Toxicol Appl Pharmacol 153:186–198; doi: 10.1006/taap.1998.8533 .
View Abstract
Topics: PCBs , Toxicology
Gerhardt B, Kordas TJ, Thompson CM , Patel P, Vida TV. 1998. The vesicle transport protein, Vps33p, is an ATP binding protein that localizes to the cytosol in an energy dependent manner. J Biol Chem 273(25):15818–15829; doi: 10.1074/jbc.273.25.15818 .
View Abstract
Topics: Toxicology
Thompson CM , Kawashima H, and Strobel HW. 1998. Isolation of partially purified P450 2D18 and characterization of activity towards the tricyclic antidepressants imipramine and desipramine. Arch Biochem Biophys 359(1):115–121; doi: 10.1006/abbi.1998.0892 .
View Abstract